参考文献/References:
[1] 仝玉珠.腹腔镜下全面分期手术治疗早期卵巢癌疗效观察[J].新乡医学院学报,2018,35(9):804-806.
[2] 范群,李玉芳,范姜铱柔,等.血清HE4、TSGF和CA125联合检测诊断卵巢癌的价值[J].海南医学,2015,26(11):1634-1636.
[3] ZHANG F,ZHANG Z L.The diagnostic value of transvaginal sonograph (TVS),color Doppler,and serum tumor marker CA125,CEA,and AFP in ovarian cancer[J].Cell Biochem Biophys,2015,72(2):353-357.
[4] 辜卫红,胡天惠,薛涛.血清CA125、HE4联合阴道彩色多普勒在卵巢癌高危人群早期筛查中的临床价值[J].重庆医学,2017,46(12):1613-1615.
[5] 贺帅,马黎明,来艳君.HE4、CA125、SMRP检测联合ROMA在卵巢癌诊断中的应用[J].实用癌症杂志,2019,34(3):362-364,368.
[6] 王静,陶健,袁超.卵巢癌患者联合检测血清TK1、CA125的临床价值[J].中华全科医学,2014,12(6):975-976.
[7] 胡晓琳,王凤,魏佳宁,等.血清糖类抗原125、人附睾蛋白4及卵巢癌风险预测模型指数在卵巢恶性肿瘤诊断中的重要价值[J].中国老年学杂志,2017,37(4):908-909.
[8] 何树泉.血清HE4和CA125联合检测对卵巢癌的临床诊断价值探讨[J].数理医药学杂志,2016,29(11):1607-1608.
[9] HAMED E O,AHMED H,SEDEEK O B,et al.Significance of HE4 estimation in comparison with CA125 in diagnosis of ovarian cancer and assessment of treatment response[J].Diagn Pathol,2013,8(1):1-8.
[10] 高磊,刘晓霞,王泳心,等.血清糖类抗原125和人附睾蛋白4联合检测在卵巢癌诊断中的价值[J].中国老年学杂志,2016,36(12):2958-2959.
[11] GUERRIERO S,ALCAZAR J L,AJOSSA S,et al.Transvaginal color Doppler imaging in the detection of ovarian cancer in a large study population[J].Int J Gynecol Cancer,2010,20(5):781-786.
[12] 胥琳璟,郑晓霞,王斌,等.血清HE4、CA125联合TVCDS诊断早期卵巢癌的应用分析[J].河北医药,2017,39(5):668-670.
[13] 尹艳英,李娜,袁莉.血清HE4、CA125联合经阴道彩色多普勒超声诊断卵巢癌的临床价值[J].医学研究杂志,2014,43(6):132-134.
[14] QIU J J,LIU M H,ZHANG Z X,et al.Transvaginal color Doppler sonography predicts ovarian interstitial fibrosis and microvascular injury in women with ovarian endometriotic cysts[J].Acta Obstet Gynecol Scand,2012,91(5):605-612.
[15] 朱苏兰,鲁陈,何莹.血清CA125、HE4联合检测在卵巢癌早期诊断中的应用分析[J].现代诊断与治疗,2014,25(13):2998-2999.
[16] 梁建林,潘小萍,赵哓峰.血清 HE4与 CA125联合检测在早期卵巢癌诊断中的应用价值探讨[J].内蒙古医科大学学报,2015,37(6):580-582.
[17] GORP T V,CADRON I,DESPIERRE E,et al.HE4 and CA125 as a diagnostic test in ovarian cancer:prospective validation of the risk of ovarian malignancy algorithm[J].Br J Cancer,2011,104(5):863-870.
[18] 陈宗波,陈展泽,李国选,等.人血清附睾蛋白4和糖类抗原125联合检测对卵巢癌的诊断价值[J].检验医学与临床,2014,11(6):749-751.
[19] 雷震山,高鹏,吴金斌.联合检测血清HE4和CA125对卵巢癌患者的临床诊断价值探讨[J].国际检验医学杂志,2016,37(4):544-546.
[20] KONDALSAMY-CHENNAKESAVAN S,HACKETHAL A,BOW-TELL D,et al.Differentiating stage 1 epithelial ovarian cancer from benign ovarian tumours using a combination of tumour markers HE4,CA125,and CEA and patient′s age[J].Gynecol Oncol,2013,129(3):467-471.
相似文献/References:
[1]任 波.胃癌患者化学治疗前后血清血红蛋白、血管内皮生长因子、癌胚抗原、糖链抗原19-9和糖链抗原125水平变化及临床意义[J].新乡医学院学报,2017,34(11):998.[doi:10.7683/xxyxyxb.2017.11.011]
REN Bo.Clinic significant change of serum hemoglobin,vascular endothelial growth factor,carcinoembryonic antigen,carbohydrate antigen 19-9 & carbohydrate antigen 125 in gastric cancer patients chemotherapy[J].Journal of Xinxiang Medical University,2017,34(10):998.[doi:10.7683/xxyxyxb.2017.11.011]